In addition, in a recent study on 471 NAFLD patients prospectively enrolled and followed for a median of 5.4 years, a twofold increased risk of severe liver disease among carriers of the C > G allele of PNPLA3 was reported.38 The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.